<DOC>
	<DOCNO>NCT00926419</DOCNO>
	<brief_summary>This study aim assess immunogenicity safety nd influence delivery system ( needle-free injector syringe needle ) fractional dos ( dose spar ) two vaccine ( Varicella Hepatitis A vaccine ) child age 13 30 month .</brief_summary>
	<brief_title>Serological Evaluation Varicella Hepatitis A Vaccines Using Injector Delivery</brief_title>
	<detailed_description>The purpose study evaluate immunogenicity , safety influence delivery system ( needle-free injector syringe needle ) fractional dos ( dose spar ) ( 23,3 43,3 PFU - plaque-forming unit - live attenuate OKA strain Varicella-zoster virus 100 radioimmunoassay unit HAV ) chickenpox Hepatitis A ( vaccine , intradermally administer , compare full dose 103,3 PFU , subcutaneously administer , 600 primo ( first ) vaccinate child age 13 30 month select random day care center São Paulo . Vaccines test sequentially ( Varicella day 0 Hepatitis A day 45 ) . Only 400 child randomize Hepatitis A vaccine testing , remain 200 child receive regular dose Hepatitis A vaccine without assessment . Doses administer use two system : Disposable Needle-free Syringe Jet Injector ( DSJI ) , compare conventional procedure use syrinx needle . Serial blood sample blindly analyze detect antibody seroconversion . Local systemic adverse event assess accord definition establish Brighton Collaboration Group , 24 72 hour , 7 day , 14 day , 21 day 45 day vaccination , clinical evaluation telephone call .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Chickenpox</mesh_term>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Children gender older 13 month young 30 month age . Available followup least 45 day public day care center fund São Paulo City local government . Written inform consent sign parent legal guardian read explanation Suspect/verified diagnosis congenital acquire immunodeficiency syndrome ( AIDS ) Suspect/verified diagnosis malign neoplasia Children treatment highdose systemic corticosteroid ( equivalent prednisone 2 mg/kg/day , two week ) , immunosuppressive therapy . Received vaccine live attenuate strain virus within less 30 day Suspect/verified diagnosis chickenpox already immunize chickenpox ( varicella ) . Suspect/verified diagnosis hypersensibility ingredient vaccine . One parent legal guardian minor agree study . Any circumstance may potentially damage minor prevent procedure carry accord evaluation research team . Child show sign symptom active intercurrent disease ( e.g . fever , rash , etc . ) may interfere evaluation adverse event immunization research team 's discretion . In case , participant may reevaluate within follow three month order verify eligibility .</criteria>
	<gender>All</gender>
	<minimum_age>13 Months</minimum_age>
	<maximum_age>30 Months</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Varicella</keyword>
	<keyword>Hepatitis A</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Injector</keyword>
	<keyword>Fractional dose</keyword>
	<keyword>Intradermal</keyword>
	<keyword>Children</keyword>
</DOC>